| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/2000 | WO2000004886A1 Formulations for the transdermal administration of fenoldopam |
| 02/03/2000 | WO2000004884A1 Pharmaceutical preparations for the topical treatment of mucocutaneous herpes infections and herpetic keratitis of the eye |
| 02/03/2000 | WO2000004883A1 Diltiazem controlled release formulation and method of manufacture |
| 02/03/2000 | WO2000004882A1 Formulations of anionic polysaccharides |
| 02/03/2000 | WO2000004881A1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 02/03/2000 | WO2000004880A1 A wet granulation method for preparing a stable pharmaceutical formulation |
| 02/03/2000 | WO2000004879A1 Granule modulating hydrogel system |
| 02/03/2000 | WO2000004878A1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 02/03/2000 | WO2000004877A1 Suppository formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004875A2 Preparation of aqueous clear solution dosage forms with bile acids |
| 02/03/2000 | WO2000004870A2 Composition for enhancing epidermal lipid production |
| 02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | WO2000004866A2 Preparation of thioarabinofuranosyl compounds and use thereof |
| 02/03/2000 | WO2000004865A2 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 02/03/2000 | WO2000004862A2 Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 02/03/2000 | WO1999066903A3 Large porous particles emitted from an inhaler |
| 02/03/2000 | WO1999065922A3 Prenyl transferase inhibitors |
| 02/03/2000 | WO1999064417A3 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/03/2000 | WO1999064001A3 Methods and compositions for increasing penetration of hiv protease inhibitors |
| 02/03/2000 | WO1999063942A3 Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated 'agelagalastatin' |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 02/03/2000 | WO1999063928A3 Pharmaceutical product for hemophilia and asthmatic bronchitis treatment |
| 02/03/2000 | WO1999061444A3 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/03/2000 | WO1999058504A9 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/03/2000 | WO1999054459A8 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 02/03/2000 | WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/03/2000 | WO1999050251A3 Cyclin dependent kinase inhibitors |
| 02/03/2000 | WO1999034786A3 Lipase inhibiting polymers |
| 02/03/2000 | WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 02/03/2000 | WO1998050365A9 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 02/03/2000 | DE19837116C1 Use of paracetamol as an appetite depressant to reduce body weight |
| 02/03/2000 | DE19834816A1 Verwendung von Ectoin oder Ectoin-Derivaten in kosmetischen Formulierungen Use of ectoine or ectoine derivatives in cosmetic formulations |
| 02/03/2000 | DE19834813A1 Use of glycerin and/or glycol esters of aliphatic 20-40C fatty acids, e.g., glyceryl behenate, to strengthen the barrier function of skin, e.g., to protect against skin aging |
| 02/03/2000 | DE19834751A1 Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel Disubstituted bicyclic heterocycles, their preparation and their use as medicaments |
| 02/03/2000 | DE19834714A1 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 2,3,3a, 4,9,9a-hexahydro-8-hydroxy-1H-ben [f] indoles, to processes for their preparation and their use as medicaments |
| 02/03/2000 | DE19834713A1 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New phenylethylamine derivatives, processes for their preparation and their use as medicaments |
| 02/03/2000 | DE19834604A1 Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine and 1-(5-hydroxyhexyl)-3-methyl-7-n-propylxanthine as phosphodiesterase V inhibitors to prepare medicaments for treating erectile dysfunction |
| 02/03/2000 | DE19834507A1 Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil Pharmaceutical, water-soluble tablet formulation for use of sildenafil |
| 02/03/2000 | DE19834506A1 Transmucosales therapeutisches System zur Anwendung von Sildenafil Transmucosal therapeutic system for the administration of sildenafil |
| 02/03/2000 | DE19834505A1 Transdermal therapeutic system useful for treating male sexual impotence contains sildenafil |
| 02/03/2000 | DE19834047A1 Substituierte Pyrazolderivate Substituted pyrazole derivatives |
| 02/03/2000 | DE19834045A1 (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin (4-amino-5-ethylpyrimidine-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine |
| 02/03/2000 | DE19834044A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives |
| 02/03/2000 | DE19832784A1 Continuous production of fatty acid esters from a biological source by contact with an inert catalyst |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2338397A1 Methods for purifying nucleic acids |
| 02/03/2000 | CA2338329A1 The use of cd4-binding small molecules to inhibit hiv infection |
| 02/03/2000 | CA2338328A1 Small molecule inhibitors of bcl-2 proteins |
| 02/03/2000 | CA2338310A1 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 02/03/2000 | CA2338305A1 Imidazole compounds |
| 02/03/2000 | CA2338279A1 Imidazoline receptor binding compounds |
| 02/03/2000 | CA2338222A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof |
| 02/03/2000 | CA2338216A1 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 02/03/2000 | CA2338211A1 Use of glucose uptake enhancer for reducing apoptosis |
| 02/03/2000 | CA2338209A1 Biphenyl derivatives |
| 02/03/2000 | CA2338198A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 02/03/2000 | CA2338147A1 Substituted benzimidazole antiviral agents |
| 02/03/2000 | CA2338044A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 02/03/2000 | CA2337954A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/03/2000 | CA2337945A1 .alpha.-amino acid phenyl ester derivatives |
| 02/03/2000 | CA2337941A1 N,n-substituted cyclic amine compounds |
| 02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | CA2337413A1 Substituted phenylamidines,pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/03/2000 | CA2337399A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | CA2337349A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | CA2337247A1 Isquinolines as urokinase inhibitors |
| 02/03/2000 | CA2336595A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | CA2335620A1 Solid preparation containing sparingly soluble nsaids |
| 02/03/2000 | CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/02/2000 | EP0976776A1 Hypertonic aqueous dispersions of unfractioned collagen, a method and a device for the preparation of said dispersions |
| 02/02/2000 | EP0976754A1 Remedies/preventives for respiratory diseases |
| 02/02/2000 | EP0976752A1 C-2 S/O- and S/N-Formaldehyde acetal derivatives of carbapenem antibiotics |
| 02/02/2000 | EP0976749A1 Process for preparing quinolone and naphthyridone carboxylic acids |
| 02/02/2000 | EP0976748A1 Pyrrolidine derivatives having phospholipase a2 inhibitory activity |
| 02/02/2000 | EP0976747A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders |
| 02/02/2000 | EP0976744A1 Amide, carbamate, and urea derivatives having glutamate receptor function potentiating activity |
| 02/02/2000 | EP0976742A1 A synthesis of furan sulfonamide compounds useful in the synthesis of IL-1 inhibitors |
| 02/02/2000 | EP0976734A2 Selective inhibitors of viral or bacterial neuraminidase |
| 02/02/2000 | EP0976732A1 1,4-substituted cyclic amine derivatives |
| 02/02/2000 | EP0976408A1 Cation exchange resin preparation containing gelling agent |
| 02/02/2000 | EP0976407A1 Antiseptic composition |
| 02/02/2000 | EP0976406A1 Transdermal composition containing glibenclamide and benzyl alcohol |
| 02/02/2000 | EP0976404A2 A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal |
| 02/02/2000 | EP0976398A2 Use of 3,4-diphenyl chroman derivatives in the manufacture of a medicament for lowering serum cholesterol levels and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| 02/02/2000 | EP0976395A1 Tablet for extended release of a drug in the stomach |
| 02/02/2000 | EP0976381A1 Dermatologic preparation |
| 02/02/2000 | EP0975774A2 Bacterial plasmids |
| 02/02/2000 | EP0975766A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 02/02/2000 | EP0975754A1 Osteoprotegerin binding proteins and receptors |
| 02/02/2000 | EP0975750A2 Modified retinoblastoma tumor suppressor proteins |
| 02/02/2000 | EP0975739A1 Stimulation, culture and preservation of pancreatic and other cells |
| 02/02/2000 | EP0975680A1 Interactive system for substance presentation and elimination |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975654A1 Composition and method for treatment of cmv infections |
| 02/02/2000 | EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 02/02/2000 | EP0975650A1 Oligomers which inhibit expression of collagen genes |
| 02/02/2000 | EP0975649A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies |